ARGX241220P570000
- 3.09
- -1.81-36.94%
argenx SE Newsroom
Argenx Is Maintained at Outperform by Evercore ISI Group
Evercore Maintains Argenx SE(ARGX.US) With Buy Rating, Maintains Target Price $706
Oppenheimer Maintains Argenx SE(ARGX.US) With Buy Rating, Raises Target Price to $675
Jefferies Maintains Argenx SE(ARGX.US) With Buy Rating, Maintains Target Price $689
Jefferies Sticks to Their Buy Rating for Argenx Se (ARGX)
A Quick Look at Today's Ratings for Argenx SE(ARGX.US), With a Forecast Between $606 to $770
Argenx Analyst Ratings
Argenx Se's Promising Clinical Advancements and Positive ALKIVIA Study Results Underpin Buy Rating
Morgan Stanley Maintains Argenx SE(ARGX.US) With Buy Rating, Raises Target Price to $675
Truist Financial Maintains Argenx SE(ARGX.US) With Buy Rating
Morgan Stanley Raises Price Target on Argenx to $675 From $580, Keeps Overweight Rating
Argenx Analyst Ratings
Wolfe Research Upgrades Argenx SE(ARGX.US) to Buy Rating, Announces Target Price $697
BofA Securities Maintains Argenx SE(ARGX.US) With Buy Rating, Maintains Target Price $670
Analysts Are Bullish on These Healthcare Stocks: Argenx Se (ARGX), Regeneron (REGN)
Truist Financial Maintains Argenx SE(ARGX.US) With Buy Rating, Maintains Target Price $660
Scotiabank Upgrades Argenx SE(ARGX.US) to Buy Rating, Raises Target Price to $715
Stifel Maintains Argenx SE(ARGX.US) With Buy Rating, Raises Target Price to $707
Stifel Nicolaus Sticks to Their Buy Rating for Argenx Se (ARGX)
J.P. Morgan Maintains Argenx SE(ARGX.US) With Buy Rating, Raises Target Price to $670